GGrantIndex
Sort

11,323 grants matching glioblastoma

The novel PRMT5-substrate adaptor interface provides a therapeutic target in MTAP null tumors

$67,446
Kathleen Mulvaney · Broad Institute, Inc. · F32 · FY2020 · CA

Mismatch Repair Proteins as Drivers of Temozolomide Resistance in Glioblastoma

$67,446
Adam Nathaniel Boynton · Dana-Farber Cancer Inst · F32 · FY2020 · CA

Deep Proteomics of Normal Human Ovarian Surface Epithelium and Fallopian Tube Epi

$67,089
Karin D. Rodland · Battelle Pacific Northwest Laboratories · U24 · FY2014 · CA

Cancer Genomics and Epigenomics

$66,995
Jean Gautier · Columbia University Health Sciences · P30 · FY2021 · CA

Cancer Genomics and Epigenomics

$66,995
Jean Gautier · Columbia University Health Sciences · P30 · FY2020 · CA

Cancer Genomics and Epigenomics

$66,995
Jean Gautier · Columbia University Health Sciences · P30 · FY2022 · CA

Cancer Genomics and Epigenomics

$66,995
Jean Gautier · Columbia University Health Sciences · P30 · FY2023 · CA

Cancer Genomics and Epigenomics

$66,993
Jean Gautier · Columbia University Health Sciences · P30 · FY2024 · CA

Clinical Research Program

$66,766
Matthew I Milowsky · Univ Of North Carolina Chapel Hill · P30 · FY2025 · CA

Truncated GLI1 In Glioblastoma

$66,640
Hui-Wen Lo · Wake Forest University Health Sciences · R01 · FY2016 · NS

Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma

$66,634
Katherine E Warren · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

KDM1A inhibitors as novel therapeutics for glioblastoma

$66,632
Gangadhara R Sareddy · University Of Texas Hlth Science Center · R01 · FY2020 · NS

Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma

$66,615
Katherine E Warren · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

IMMUNOLOGY AND CANCER IMMUNOTHERAPY RESEARCH PROGRAM

$66,500
Randolph J. Noelle · Dartmouth College · P30 · FY2011 · CA

Cancer Immunotherapy Through Intratumoral Activation of Recall Responses

$66,446
Michael Clavon Brown · Duke University · F32 · FY2020 · CA

Convertible MRI contrast signaling delivery and release of anti-glioma nano-drug

$66,401
Dawen Zhao · Ut Southwestern Medical Center · R01 · FY2015 · CA

microRNA therapies for advanced brain tumors

$66,365
Deepak Bhere · University Of South Carolina At Columbia · R00 · FY2024 · CA

PHASE II TRIAL OF EMD 121974 FOR RECURRENT GLIOBLASTOMA: A CLINICAL TRIAL WIT

$66,284
Timothy Cloughesy · University Of California Los Angeles · M01 · FY2007 · RR

Treatment of glioblastoma using targeted nanoparticles

$66,200
Gil Covarrubias · Case Western Reserve University · U01 · FY2018 · CA

Mays Cancer Center at UT Health SA

$66,054
Ratna K Vadlamudi · University Of Texas Hlth Science Center · P30 · FY2025 · CA

Targeted STAT3 inhibition impairs MDSC mobilization and recruitment in glioblastoma

$65,994
Christina Anna Elizabeth Von Roemeling · University Of Florida · F32 · FY2021 · CA

Engineering knotted peptide therapeutics for pediatric brain tumor patients

$65,741
James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA

Apical-basal polarity signaling in glioblastoma

$65,622
Sourav Ghosh · University Of Arizona · R01 · FY2013 · CA

p52 induces mesenchymal differentiation in glioblastoma

$65,606
David J Voce · University Of Chicago · F32 · FY2019 · CA

Investigating the role of SPRY2 in regulating drug resistance of GBM tumors and interactions between GBM tumor cells and macrophages

$65,606
Nisha Gowri Sosale · University Of Virginia · F32 · FY2019 · CA